biospecimen_aliquot__bcr_aliquot_barcode	tcga-bh-a0h0-01a-11w-a071-09
biospecimen_aliquot__bcr_aliquot_uuid	69110467-4cf5-4b5d-a2dd-b1c91e786959
biospecimen_aliquot__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
biospecimen_aliquot__bcr_sample_barcode	tcga-bh-a0h0-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099016459
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.50
biospecimen_aliquot__date_of_shipment	2010-09-08
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a071
biospecimen_aliquot__plate_row	a
biospecimen_aliquot__quantity	40.00
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__analyte_type	repli-g (qiagen) dna
biospecimen_analyte__analyte_type_id	w
biospecimen_analyte__bcr_analyte_barcode	tcga-bh-a0h0-01a-11w
biospecimen_analyte__bcr_analyte_uuid	d11b0bff-32a1-42c1-aa02-4f073e8bba81
biospecimen_analyte__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
biospecimen_analyte__bcr_sample_barcode	tcga-bh-a0h0-01a
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-bh-a0h0
biospecimen_diagnostic_slides__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-bh-a0h0-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	b3b394dd-1f4e-42ca-bb51-c002e423b3d0
biospecimen_normal_control__bcr_patient_barcode	tcga-bh-a0h0
biospecimen_normal_control__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
biospecimen_normal_control__normal_tissue_anatomic_site	breast
biospecimen_portion__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
biospecimen_portion__bcr_portion_barcode	tcga-bh-a0h0-01a-11
biospecimen_portion__bcr_portion_uuid	962e74e2-5821-4351-933d-9f7252ab21b6
biospecimen_portion__bcr_sample_barcode	tcga-bh-a0h0-01a
biospecimen_portion__date_of_creation	2010-06-08
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-bh-a0h0-01a-11w
biospecimen_protocol__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
biospecimen_protocol__bcr_sample_barcode	tcga-bh-a0h0-01a
biospecimen_protocol__experimental_protocol_type	repli-g
biospecimen_sample__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
biospecimen_sample__bcr_sample_barcode	tcga-bh-a0h0-01a
biospecimen_sample__bcr_sample_uuid	93a3fc8a-1b50-4da3-9dbb-cf9f582fc22e
biospecimen_sample__days_to_collection	344
biospecimen_sample__initial_weight	70
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-bh-a0h0.94cf5704-1be7-4ccc-870e-fb8527ac47e8.pdf
biospecimen_sample__pathology_report_uuid	94cf5704-1be7-4ccc-870e-fb8527ac47e8
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
biospecimen_slide__bcr_sample_barcode	tcga-bh-a0h0-01a
biospecimen_slide__bcr_slide_barcode	tcga-bh-a0h0-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	70fed29e-bd3c-4cb6-92c4-0c16bd6048d6
biospecimen_slide__image_file_name	tcga-bh-a0h0-01a-01-tsa.70fed29e-bd3c-4cb6-92c4-0c16bd6048d6.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	15
biospecimen_slide__percent_tumor_cells	85
biospecimen_slide__percent_tumor_nuclei	90
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-bh-a0h0
biospecimen_tumor_sample__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
clinical_drug__bcr_drug_barcode	tcga-bh-a0h0-d4700
clinical_drug__bcr_drug_uuid	a14326db-605d-438e-8a8a-4f5740293909
clinical_drug__bcr_patient_barcode	tcga-bh-a0h0
clinical_drug__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
clinical_drug__form_completion_date	2010-11-17
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	67
clinical_drug__prescribed_dose	1
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-bh-a0h0-f4704
clinical_follow_up__bcr_followup_uuid	f6601ba3-50ac-41e2-b50d-cc6128a123b6
clinical_follow_up__bcr_patient_barcode	tcga-bh-a0h0
clinical_follow_up__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
clinical_follow_up__form_completion_date	2010-11-16
clinical_follow_up__last_contact_days_to	461
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_nte__bcr_patient_barcode	tcga-bh-a0h0
clinical_nte__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
clinical_patient__age_at_diagnosis	69
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage ia
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	right upper outer quadrant|right
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-bh-a0h0
clinical_patient__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
clinical_patient__birth_days_to	-25223
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	2+
clinical_patient__er_positivity_method	h-score 190
clinical_patient__er_positivity_scale_other	h-score
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	50-59%
clinical_patient__first_surgical_procedure_other	segmental mastectomy
clinical_patient__form_completion_date	2010-11-10
clinical_patient__gender	female
clinical_patient__her2_ihc_percent_positive	<10%
clinical_patient__her2_ihc_score	0
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	461
clinical_patient__lymph_nodes_examined_count	2
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0h0
clinical_patient__pr_positivity_define_method	h-score 7
clinical_patient__pr_positivity_ihc_intensity_score	2+
clinical_patient__pr_positivity_scale_other	h-score
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	other
clinical_patient__tissue_source_site	bh
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-bh-a0h0
clinical_radiation__bcr_patient_uuid	96457ebf-ae88-41f4-97e5-cdc3163418aa
clinical_radiation__bcr_radiation_barcode	tcga-bh-a0h0-r4702
clinical_radiation__bcr_radiation_uuid	bdb65034-26a9-4ffc-b432-29ccd467d1fd
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-11-17
clinical_radiation__radiation_adjuvant_fractions_total	36
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	148
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	97
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6640
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0H0-01A-11W-A071-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0H0-01A-11W-A071-09.bed.meta
manually_curated__id	tcga-bh-a0h0-01a-11w-a071-09
manually_curated__md5sum	59797be9f78ae8381dabc8fde0c3bd34
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	69110467-4cf5-4b5d-a2dd-b1c91e786959
manually_curated__tumor_tag	brca
